Upgrade: Analysts Just Made A Sizeable Increase To Their Shanghai MicroPort MedBot (Group) Co., Ltd. (HKG:2252) Forecasts

Simply Wall St.04-12 08:14

Celebrations may be in order for Shanghai MicroPort MedBot (Group) Co., Ltd. (HKG:2252) shareholders, with the analysts delivering a significant upgrade to their statutory estimates for the company. ...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2626175765?lang=en_US&edition=fundamental","thumbnail":"https://images.simplywall.st/asset/industry/6021000-choice1-main-header/1585186659638","is_english":true,"pubTime":"2026-04-12 08:14","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2626175765","market":"hk","top_or_hot":-1,"title":"Upgrade: Analysts Just Made A Sizeable Increase To Their Shanghai MicroPort MedBot (Group) Co., Ltd. (HKG:2252) Forecasts","media":"Simply Wall St.","content":"<div>\n<p>Celebrations may be in order for Shanghai MicroPort MedBot (Group) Co., Ltd. (HKG:2252) shareholders, with the analysts delivering a significant upgrade to their statutory estimates for the company.  ...</p>\n\n<a href=\"https://simplywall.st/stocks/hk/healthcare/hkg-2252/shanghai-microport-medbot-group-shares/news/upgrade-analysts-just-made-a-sizeable-increase-to-their-shan\">Source Link</a>\n\n</div>\n","source":"simplywall_highlight","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Upgrade: Analysts Just Made A Sizeable Increase To Their Shanghai MicroPort MedBot (Group) Co., Ltd. (HKG:2252) Forecasts</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nUpgrade: Analysts Just Made A Sizeable Increase To Their Shanghai MicroPort MedBot (Group) Co., Ltd. (HKG:2252) Forecasts\n</h2>\n\n<h4 class=\"meta\">\n\n\n2026-04-12 08:14 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://simplywall.st/stocks/hk/healthcare/hkg-2252/shanghai-microport-medbot-group-shares/news/upgrade-analysts-just-made-a-sizeable-increase-to-their-shan><strong>Simply Wall St.</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Celebrations may be in order for Shanghai MicroPort MedBot (Group) Co., Ltd. (HKG:2252) shareholders, with the analysts delivering a significant upgrade to their statutory estimates for the company.  ...</p>\n\n<a href=\"https://simplywall.st/stocks/hk/healthcare/hkg-2252/shanghai-microport-medbot-group-shares/news/upgrade-analysts-just-made-a-sizeable-increase-to-their-shan\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"02252","symbol_name":"微创机器人-B","start_time":0,"source_url":"https://simplywall.st/stocks/hk/healthcare/hkg-2252/shanghai-microport-medbot-group-shares/news/upgrade-analysts-just-made-a-sizeable-increase-to-their-shan","article_id":"2626175765","we_media_id":null,"thumbnails":["https://images.simplywall.st/asset/industry/6021000-choice1-main-header/1585186659638"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/hk/healthcare/hkg-2252/shanghai-microport-medbot-group-shares/news/upgrade-analysts-just-made-a-sizeable-increase-to-their-shan","rn_cache_url":null,"directOrigin":true},"url":"https://stock-news.laohu8.com/highlight/detail?id=2626175765","pubTimestamp":1775952891,"columns":[],"sourceInfo":{"source_id":"simplywall_highlight","name":"Simply Wall St."},"weMediaInfo":null,"summary":"Celebrations may be in order for Shanghai MicroPort MedBot (Group) Co., Ltd. ( HKG:2252 ) shareholders, with the...","collect":0,"end_time":0,"defaultTopTitle":"simplywall.st","property":["rate"],"viewcount":null,"language":"en","relate_stocks":{"02252":"微创机器人-B"},"translate_title":"升级：分析师刚刚大幅上调了对上海微创医疗机器人（集团）有限公司（HKG：2252）的预测","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"02252":1.5},"content_text":"Celebrations may be in order for Shanghai MicroPort MedBot (Group) Co., Ltd. (HKG:2252) shareholders, with the analysts delivering a significant upgrade to their statutory estimates for the company.   The analysts greatly increased their revenue estimates, suggesting a stark improvement in business fundamentals.      The market seems to be pricing in some improvement in the business too, with the stock up 7.7% over the past week, closing at HK$28.50.  Could this big upgrade push the stock even higher?   AI is about to change healthcare. These 20 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10bn in marketcap - there is still time to get in early. After the upgrade, the six analysts covering Shanghai MicroPort MedBot (Group) are now predicting revenues of CN¥1.1b in 2026. If met, this would reflect a sizeable 107% improvement in sales compared to the last 12 months.     The losses are expected to disappear over the next year or so, with forecasts for a profit of CN¥0.094 per share this year.      Prior to this update, the analysts had been forecasting revenues of CN¥978m and earnings per share (EPS) of CN¥0.023 in 2026.        So we can see there's been a pretty clear increase in analyst sentiment in recent times, with both revenues and earnings per share receiving a decent lift in the latest estimates.     View our latest analysis for Shanghai MicroPort MedBot (Group) SEHK:2252 Earnings and Revenue Growth April 12th 2026  With these upgrades, we're not surprised to see that the analysts have lifted their price target 8.3% to CN¥30.99 per share.        It could also be instructive to look at the range of analyst estimates, to evaluate how different the outlier opinions are from the mean.  There are some variant perceptions on Shanghai MicroPort MedBot (Group), with the most bullish analyst valuing it at CN¥36.75 and the most bearish at CN¥21.06 per share.   These price targets show that analysts do have some differing views on the business, but the estimates do not vary enough to suggest to us that some are betting on wild success or utter failure.      Of course, another way to look at these forecasts is to place them into context against the industry itself.     It's clear from the latest estimates that Shanghai MicroPort MedBot (Group)'s rate of growth is expected to accelerate meaningfully, with the forecast 107% annualised revenue growth to the end of 2026 noticeably faster than its historical growth of 72% p.a. over the past five years.    By contrast, our data suggests that other companies (with analyst coverage) in a similar industry are forecast to grow their revenue at 23% per year.  It seems obvious that, while the growth outlook is brighter than the recent past, the analysts also expect Shanghai MicroPort MedBot (Group) to grow faster than the wider industry.     AdvertisementThe Bottom Line  The biggest takeaway for us from these new estimates is that analysts upgraded their earnings per share estimates, with improved earnings power expected for this year.        They also upgraded their revenue estimates for this year, and sales are expected to grow faster than the wider market.         With a serious upgrade to expectations and a rising price target, it might be time to take another look at Shanghai MicroPort MedBot (Group).     Still, the long-term prospects of the business are much more relevant than next year's earnings.   We have estimates - from multiple Shanghai MicroPort MedBot (Group) analysts - going out to 2028, and you can see them free on our platform here.  Another way to search for interesting companies that could be  reaching an inflection point is to track whether management are buying or selling, with our free list of growing companies backed by insiders. New: Manage All Your Stock Portfolios in One PlaceWe've created the ultimate portfolio companion for stock investors, and it's free.• Connect an unlimited number of Portfolios and see your total in one currency• Be alerted to new Warning Signs or Risks via email or mobile• Track the Fair Value of your stocksTry a Demo Portfolio for FreeHave feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.40.0","shortVersion":"4.40.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2626175765","isCrawlerRequest":true}